Thromboangiitis obliterans (TAO) is a nonatherosclerotic segmental inflammatory obliterative disease that most commonly affects the small-and medium-sized arteries and veins in both upper and lower extremities. In the past, TAO was exclusively a disease confined to men; however, recently more women have been diagnosed with TAO. Most patients are heavy users of tobacco, and usually cigarette smokers.
Introduction
TAO was first described by von Winiwarter ' in 1879 after he performed an autopsy on a 57-year-old patient with a 12-year history of leg ischemia complicated by spontaneous gangrene and amputation. Pathologic examination of the amputated leg showed occlusions of the small arteries and veins by a hypercellular thrombus with preservation of the internal elastic membrane. Von Winiwarter ' suggested that the endarteritis and endophlebitis that was present in the amputated specimen was distinctive from atherosclerosis. However, the disease was not recognized as a distinct clinical entity until 1908 when Leo Buerger provided a detailed pathological description in 11 amputated limbs. Since that time, TAO has become known as Buerger's disease.
Etiology and pathogenesis
The etiology of TAO is unknown. There is a powerful association between heavy tobacco use and TAO. IO It has been suggested that some patients may be abnormally sensitive or allergic to some component of tobacco and that this sensitivity in some way leads to small vessel occlusive disease.lv'? The incidence of TAO is higher in countries wh~re the consumption of tobacco is large. In India, many patients who develop TAO are in a low socioeconomic class and smoke 'bidis' (homemade cigarettes with raw tobacco), 8.13 .14 which may account for the higher incidence of TAO in the Indian population. Higher tobacco consumption and carboxyhemoglobin levels had been demonstrated'" in patients with TAO than in patients with atherosclerosis or in a control group of patients. However, there have been occasional cases of TAO in patients who have discontinued smoking or using tobacco but these cases have not been well documented. 16 TAO has also been reported'I:" in users of smokeless tobacco or snuff. It is not know.n whether cigarette smoking is causative or merely contnbutory to the development of TAO. Tobacco use is a major factor in disease progression and continued symptoms. associated with TAO. While passive (involuntary) smoking has not been shown to be associated with the onset of TAO, it may be an important factor in the continuation of symptoms in patients during the acute phase of TAO.
There have been several studies examining the immunologic mechanism in patients with TAO. Increased cellular and humoral immune response to human collagen has been reported19.20 in patients with TAO. Circulating immune complexes have been found 21.22 in the peripheral arteries of patients with TAO.
Several studies lO, [23] [24] [25] [26] [27] have raised the possibility of a genetic predisposition to the development of TAO. There are considerable differences found in the human lymphocyte antigen (HLA) among patients from various populations. A significant increase in HLA-A9 and HLA-B5,23 HLA-Al an~HLA-.B8,2S and HLA-DR4 1O has been reported in patients WIth TAO. In one study26 no distinctive pattern was identifiable in patients with TAO. These differences iñ A .antigens i~pati~nts with TAO may be based on genetic differences 1D vanous populations as well as methodological differences in each of the studies cited.
Older reports" had failed to identify a specific hypercoagulable state in patients with TAO. More recently, an 1358-863X(97)VM162CR increase in urokinase plasminogen activator release and a decrease in plasminogen activator inhibitor I release have been described'" in patients with TAO, suggesting endothelial cell derangement. An increased platelet response to serotonin'" and elevated levels of serum lipoprotein (a) have been demonstrated" in patients with TAO.
Remarkable personality features were found in TAO patients in comparison with patients with coronary artery disease. 32 TAO patients were found to: (l) have more absenteeism from work, (2) smoke more before the illness developed, and continue to smoke more frequently during their illness, (3) change their place of work more often, (4) have more conflicts in their relationships, and be more often dissatisfied with their life situation, and (5) have more disciplinary problems at home and in school. sity of the periadventitial reaction may be quite variable in different segments of the same vessel. TAO is almost exclusively a disease of small-and medium-sized arteries and veins of both upper and lower limbs. There have been only occasional reports,38-40 usually without adequate histologic proof, of involvement of large elastic arteries such as the aorta, the pulmonary artery and iliac arteries. Although Buerger had noted that vascular obliteration could affect blood vessels other than those of the limbs, the involvement of the cerebral, coronary, renal and mesenteric arteries has been documented in only a few patients, almost all as single case reports. 39.41 -44 A unique case of TAO in a saphenous vein arterial graft has been reported" in a middle-aged man who continued to smoke after the myocardial revascularization surgery. Another unusual example of TAO in temporal arteries of a young smoker has been reported." Table 1 Presenting signs and symptoms
Clinical features
Reproduced from ref. 6 with permission from the American Heart Association.
Classically, TAO presents in young male smokers who often have an onset of symptoms before the age of 45 years. As noted previously, recent reports S,6.26 have suggested an increased incidence of TAO in women. The predominant clinical presentation is that of ischemia, which begins distally and usually involves the small-and medium-sized arteries and veins (Table 1) . Occasionally, large artery involvement has been reported in TAO, but this is unusual and rarely occurs in the absence of small vessel occlusive disease." Initially, patients present with ischemia or intermittent claudication of feet, legs and occasionally the hands. Foot or arch claudication may be the presenting manifestation. Foot claudication is often mistaken for an orthopedic problem and there may be considerable delay before the correct diagnosis is made. As the disease progresses more proximally, patients may present with typical calf claudication similar to that of patients with arteriosclerosis obliterans. Later in the course of the disease, patients may develop ischemic ulceration and tissue gangrene in the distal portion of the toes andlor fingers. In a series from our institution," 76% of patients had ischemic ulcerations The acute phase lesion is characterized by acute inflammation, .involving all coats of the vessel wall, especially of the veins, in association with occlusive thrombosis. Around the periphery of the thrombus, there may be collections of polymorphonuclear leukocytes with karyorrhexis, the so-called 'microabscesses', in which one or more multinucleated giant cells may be present. This histologic finding in thrombophlebitis is most characteristic of TAO.37 This striking inflammatory thrombotic lesion occurs with greater regularity in veins than in arteries and is infrequently seen when organization of the thrombus is well under way. Whether. the vascular lesions of TAO are primarily thrombotic or primarily inflammatory has never been satisfactorily settled and probably never will. In either event, the intense inflammatory infiltration and cellular proliferation seen in the acute phase lesion is distinctive, especially when the veins are involved. The intermediate stage or subacute phase is characterized by progressive organization of the occlusive thrombus in the arteries and veins, which is usually accompanied by a prominent inflammatory cell infiltrate within the thrombus and less so in the vessel wall. The chronic phase or end-stage is characterized by completed organization of the occlusive thrombus with extensive recanalization, prominent vascularization of the media and adventitial and perivascular fibrosis. In all three stages, the normal architecture of the vessel wall subjacent to the occlusive thrombus, and including the internal elastic lamina, remains essentially intact. These findings distinguish TAO from arteriosclerosis and from other systemic vasculitides.
TAO is segmental in distribution; 'skip' areas of normal vessels between diseased ones are common, and the inten-at the time of presentation. It is possible that if there was heightened awareness of the early manifestations of TAO (foot or arch claudication) then patients could be identified and treated before they developed ischemic ulcerations.
Two or more limbs are almost always involved in TAO. 18 In patients with lower extremity ulceration in whom TAO is a consideration, an Allen's test should be performed to assess the circulation in the hands and fingers." An abnormal Allen's test in a young smoker with lower extremity ulceration is highly suggestive of TAO since it demonstrates small vessel involvement of both the upper and lower extremities. An abnormal Allen 's test was reported" in 63% of patients with TAO in a series from the Cleveland Clinic.
A unique feature of TAO is the frequent involvement of the venous circulation. Approximately 40% of patients with TAO develop superficial thrombophlebitis at some time during the course of the disease." The thrombophlebitis may be migratory and may parallel disease activity.to Cold sensitivity is common and may be one of the earliest manifestations of TAO . This may be related to ischemia or to markedly increased muscle sympathetic nerve activity, as has been demonstrated" in patients with TAO compared with a control group. Typical Raynaud's phenomenon has been reported in approximately 40% of patients. Sensory findings such as numbness or tingling have been reported? in up to 70% of patients. This may be due to either severe ischemia or ischemic neuropathy secondary to encasement of the nerve fibers.
Laboratory and arteriographic findings
There is no single diagnostic test that is definitive for TAO. A complete serologic profile to exclude other diseases that can mimic TAO should be obtained. These include the following: complete blood count with differential, liver function, renal function, fasting blood sugar, urinalysis, acute phase reactants (erythrocyte sedimentation rate and Creactive protein), antinuclear antibody, rheumatoid factor, complement measurements, serologic markers for CREST syndrome and scleroderma (anticentromere antibody and SCL 70), and a complete hypercoagulability screen including antiphospholipid~tibodies, activated protein C resistance, lipoprotein (a) and homocysteine levels.
In order to exclude a proximal source of emboli, the patient may need to undergo echocardiography and arteriography. While the arteriogram may be suggestive of TAO, there are no pathognomonic angiographic findings in TAO. Proximal arteries should be normal demonstrating no evidence of atherosclerosis, aneurysm or other source of proximal emboli. The disease is confined most often to the distal circulation and is almost always infrapopliteal in the lower extremities and distal to the brachial artery in the upper extremities. There is small-and medium-sized vessel involvement such as the digital arteries in the fingers and toes, the palmar and plantar arteries in the hand and foot, as well as the tibial, peroneal, radial and ulnar arteries. 49 • SO Isolated disease below the popliteal artery is unusual in arteriosclerosis obliterans unless the patient has diabetes mellitus. Even the patient with diabetes mellitus often has multi segment disease with some evidence of proximal artery involvement. However, since diabetes is Vascular Medicine 1997: 2: 61-66
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Arteriographically, TAO is a segmental disorder, demonstrating areas of diseased vessels interspersed with normal blood vessel segments. There is often evidence of multiple vascular occlusions with collateralization around the obstructions (corkscrew collaterals) ( Figure I) . Corkscrew collaterals are not pathognomonic of TAO as they may be seen in any small vessel occlusive disease. The arteriographic appearance of TAO may be identical to that seen in patients with scleroderma or the CREST syndrome. However, the other clinical and serologic manife station s of scleroderma and CREST should help to differentiate these diseases from TAO. A useful diagnostic algorithm for the diagnosis of TAO is shown in Figure 2 .
Major and minor diagnostic criteria for the diagnosis of TAO have been proposed by Mills and Porter.' Their major criteria include the following: onset of distal extremity ischemic symptoms before the age of 45 years, tobacco abuse, undiseased arteries proximal to popliteal or brachial level , objective documentation of distal occlusive disease by fourlimb plethysmography, arteriography and/or histopathology and exclusion of proximal embolic source, trauma and local lesions, autoimmune disease, hypercoagulable states, and atherosclerosis (diabetes, hyperlipidemia, renal failure, hypertension). Their minor criteria include migratory superficial phlebitis, Raynaud's syndrome, upper extremity involvement and instep claudication. Papa, Rabi and Adar" have also attempted to establish a unified method for the diagnosis of TAO by applying a point-scoring system in the diagnosis of TAO. Points are awarded for young age at onset, foot claudication, upper extremity involvement; superficial vein thrombosis and vasospastic phenomena. Atypical features (i.e. older age, proximal location, coexistent other diseases such as atherosclerosis, diabetes and hyperlipidemia) detract points. The disease is then classified as follows:~6 points -definite, high probability; 4-5 points -probable, medium probability; 2-3 points -suspected, low probability; and 0-1 points -diagnosis excluded. The advantage of such a system is that the diagnosis of TAO would be standardized for reporting purposes. However, there is some controversy about how positive and negative points are allocated and a point system such as this does not take into consideration regional differences in the way that rare diseases present.
Treatment
The cornerstone of treatment is the complete discontinuation of cigarette smoking or the use of tobacco in any form. Other medical or surgical therapy ( Table 2) is merely palliative unless tobacco use is discontinued. It has been shown repeatedly that complete abstinence from tobacco is the only way to halt the progression of TAO and to avoid future amputations.6.7.iO.17.1l1,52,53 Even one or two cigarettes a day are enough to keep the disease active. If the patient does not have gangrene at the time of smoking cessation, the risk of amputation is extremely rare (Figure 3 ). 6 Whether passive (involuntary) smoking can cause the disease is unknown. However, patients with active TAO should probably try to avoid passive smoking as much as possible until the disease becomes quiescent.
Other than the discontinuation of tobacco, all other forms of therapy are palliative. If ischemic ulcers are present, they should be treated with local wound care (lubricate skin with lanolin-based cream or lotion, use lamb's wool between toes to prevent 'kissing' ulcers, and avoid trauma with use of a bed cradle and heel protectors). If the ulcer gets infected, debridement should be done and antibiotics administered.
In the severely ischemic patient, a reverse Trendelenburg (vascular) position should be used. Adequate narcotics should be made available during the time period of severe ischemia. Anticoagulation has not been demonstrated to be effective in TAO. If significant vasospasm is present, calcium channel-blocking agents such as nifedipine, nicardipine or amlodipine may be used. Pentoxifylline (Trental) has not been formally or adequately studied in patients with TAO. It is not unreasonable to try pentoxifylline in the severely ischemic patient; however, in our experience its benefit is small. Low-dose intra-arterial streptokinase has been used in some cases of TAO and in one series'4 it avoided or altered amputation in approximately 58% of the patients. In a prospective randomized trial," Iloprost, a prostacyclin x 2 = 14.95. P < 0.0001 analog, was found to be more effective than low-dose aspirin in relieving ischemic rest pain and allowing ulcer healing. It may be a useful modality in helping patients with critical limb ischemia get through the early time-period when they first discontinue cigarette smoking. Iloprost is not currently available in the United States. There are oral forms of Iloprost that are being studied for various forms of vascular disease. It will be interesting to see whether these oral preparations are of as much benefit in patients with TAO as the intravenous form of the drug.
When medical therapy is unsuccessful in healing ischemic ulcers, a sympathectomy (either surgical or chemical) may be of benefit in some patients, Surgical revascularization is generally not an option in patients with TAO since the disease is distal and diffuse and there is usually not a good target for bypass. Generally, the long-term results are not good with surgical bypass but an occasional patient may demonstrate benefit from revascularization.~6
